Problems with weight loss injections: what the evidence actually shows

What trial data tells us about how common these problems are

The large-scale SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and tracked tirzepatide's effects over 72 weeks. Gastrointestinal side effects were the most common reason participants needed dose adjustments or, in a small proportion, stopped treatment altogether. Nausea was reported by roughly a third to a half of participants at some point during treatment, with rates highest after starting or stepping up a dose. Vomiting, diarrhoea and constipation followed a similar pattern. Crucially, most events were described as mild to moderate in severity and tended to settle as the body adapted. The semaglutide STEP 1 trial showed a comparable picture. So the honest answer is: yes, these problems are common, particularly early on. That is not a reason to dismiss them, but it does mean that what many people experience in the first few weeks is a known and anticipated part of treatment rather than a sign that something has gone badly wrong.

One misconception worth setting aside is the idea that side effects signal the medicine is harming you. Nausea in particular is often a direct result of the slowed gastric emptying that also underlies the appetite reduction. The discomfort and the mechanism are, frustratingly, the same thing. That said, some problems do warrant proper medical attention, which the next section covers.

Serious problems: when to get medical help quickly

Most side effects from weight loss injections are self-limiting. A small number are not. In January 2026 the MHRA issued a formal Drug Safety Update following a review of GLP-1 receptor agonist medicines, identifying acute pancreatitis as an infrequent but serious risk. Severe stomach pain that starts suddenly, is persistent, and may spread to the back — with or without vomiting — should prompt a call to 111 or attendance at A&E, not a wait-and-see approach. Do not simply stop your injection without speaking to a clinician, as your wider care plan needs reviewing too.

Other symptoms that need prompt attention include signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing), significant dehydration from prolonged vomiting or diarrhoea, and any jaundice or severe pain in the upper right abdomen, which can indicate gallbladder problems associated with rapid weight loss or the medicines themselves. Changes in mood, low mood, or thoughts of self-harm have also been raised by some patients; while causality is still being studied, any deterioration in mental wellbeing during treatment deserves a conversation with your GP. Suspected side effects can be reported through the MHRA Yellow Card scheme, which continues to inform ongoing safety monitoring. If you have concerns about kidney function during treatment, there is specific guidance worth reading on whether weight loss injections can affect the kidneys.

Problems linked to the injection itself, not the medicine

A category of difficulties that often gets less attention involves technique rather than pharmacology. Injecting into the same spot repeatedly can cause localised hardening of the tissue (lipodystrophy), which slows absorption and makes the dose less predictable. Rotating sites (abdomen, outer thigh, upper arm) across each weekly injection helps. Injecting into skin that has not been allowed to warm slightly from refrigerator temperature, or into a site that has not been cleaned, can increase the risk of localised irritation or infection. For anyone new to self-injection, these details matter and are covered in the Patient Information Leaflet supplied with each pen; the NHS tirzepatide medicines page also has practical guidance written for patients.

Needle reuse is another underappreciated source of injection-site problems. Needles are designed for single use; reusing them blunts the tip and increases discomfort and localised reaction risk. If you are looking for a reliable supply, fresh compatible needles are available alongside treatment. And if you have specific questions about pancreas problems and weight loss injections, there is a dedicated page covering that topic in detail. The broader question of how different injections compare for tolerability, and whether mood changes are a documented concern, are also answered in the pages linked throughout this guide.

Managing problems and deciding whether to continue

If side effects are making treatment hard to stick with, the right person to talk to is your prescriber, not a forum. Dose titration schedules exist partly to give the body time to adjust; pausing a scheduled increase or remaining at a lower dose for longer is a clinical decision, not a failure. Eating smaller portions, avoiding very fatty or spicy food in the early weeks, staying well hydrated, and not lying down immediately after eating are practical measures that many patients find genuinely helpful, and which align with the lifestyle guidance built into treatment programmes. For an overview of how costs and access work alongside these clinical considerations, the weight loss injection cost page sets out the picture plainly.

If you are already on treatment elsewhere and finding it difficult, or if you are considering starting and want to understand the risks before committing, a prescriber-led review is the appropriate next step. Our clinical team at nume reviews every consultation personally, a real clinician reads your answers, not a scoring algorithm. If you have questions that are not answered here, our FAQs cover a wide range of common concerns, or you can reach the team directly via our contact page. If you are ready to discuss your options, speak to our prescribers through a free consultation at any point.